Arena withdrawing Belviq MAA

Arena Pharmaceuticals Inc. (NASDAQ:ARNA) disclosed in its 1Q13 financial results that it is withdrawing an MAA from EMA for Belviq lorcaserin to gain more feedback on the application for the obesity drug from EMA's CHMP. The MAA sought approval of the